Human involucrin (hINV) mRNA level and promoter activity increase when keratinocytes are treated with the differentiating agent, 12-O-tetradecanoylphorbol-13-acetate (TPA). This response is mediated via a p38 mitogen-activated protein kinase-dependent pathway that targets activator protein 1 (Efimova, T., LaCelle, P. T., Welter, J. F., and Eckert, R. L. (1998) J. Biol. Chem. 273, 24387-24395). In the present study we examine the role of various PKC isoforms in this regulation. Transfection of expression plasmids encoding the novel PKC isoforms ␦, ⑀, and increase hINV promoter activity. In contrast, neither conventional PKC isoforms (␣, , and ␥) nor the atypical isoform () regulate promoter activity. Consistent with these observations, promoter activity is inhibited by the PKC␦-selective inhibitor, rottlerin, but not by Go-6976, an inhibitor of conventional PKC isoforms, and novel PKC isoform-dependent promoter activation is inhibited by dominant-negative PKC␦. This regulation appears to be physiologically important, as transfection of keratinocytes with PKC␦, -⑀, or -increases expression of the endogenous hINV gene. Synergistic promoter activation (>100-fold) is observed when PKC⑀-or --transfected cells are treated with TPA. In contrast, the PKC␦-dependent response is more complex as either activation or inhibition is observed, depending upon PKC␦ concentration.
Human involucrin (hINV)1 is a marker of keratinocyte differentiation that is exclusively expressed in differentiated, suprabasal keratinocytes, both in vivo and in vitro (1-5). 12-OTetradecanoylphorbol-13-acetate (TPA), a keratinocytedifferentiating agent, is extensively used to induce keratinocyte differentiation. We have previously shown that TPA treatment of human keratinocytes increases hINV mRNA level and promoter activity. This increase is mediated via a Ras 3 MEKK1 3 MEK3 3 p38 signaling cascade. One target of this cascade is activator protein 1 (AP1) that binds an AP1-binding site, AP1-1, in the hINV proximal regulatory region (6 -9). A key question to be resolved is the identity of the kinase(s) that initiate this cascade and mediate the effects of TPA in normal human keratinocytes. The various isoforms of PKC are key candidates for this regulatory role.The protein kinase C (PKC) family consists of at least 11 distinct serine/threonine protein kinases that are classified into three groups. The conventional/classical PKCs (cPKCs) are calcium-, phospholipid-, and diacylglycerol-dependent (␣, I, II, and ␥); the novel PKCs (nPKCs) are calcium-independent PKCs (␦, ⑀, , , and ); and the atypical PKCs (aPKCs) are calcium-and diacylglycerol-independent (, and ) (10 -12). The differences in cofactor requirements, tissue distribution, subcellular localization, and substrate specificity suggest distinct biological functions for each PKC isozyme (10, 12, 13). Epidermal keratinocytes express ␣, ␦, ⑀, , and isoforms (14 -18). As involucrin is a model for the study of gene expression in stratifying epithelia, it is important to identify which of these PKC i...